Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sophia Mastoraki"'
Autor:
Dimitra Stergiopoulou, Athina Markou, Areti Strati, Martha Zavridou, Eleni Tzanikou, Sophia Mastoraki, Galatea Kallergi, Vassilis Georgoulias, Evi Lianidou
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-13 (2023)
Abstract Liquid biopsy (LB) provides a unique minimally invasive tool to follow-up cancer patients over time, to detect minimal residual disease (MRD), to study metastasis-biology and mechanisms of therapy-resistance. Molecular characterization of CT
Externí odkaz:
https://doaj.org/article/144fb851fcc643398e29bf3d322421cb
Autor:
Evi Lianidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki, Maria Chimonidou, Eleni Tzanikou, Areti Strati, Sophia Mastoraki
Supplementary Figure 1A Supplementary Figure 1B Supplementary Figure 2A Supplementary Figure 2B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::aac4f5877bac632e8f5bf1e396fa6151
https://doi.org/10.1158/1078-0432.22460181.v1
https://doi.org/10.1158/1078-0432.22460181.v1
Autor:
Evi Lianidou, Vassilis Georgoulias, Amanda Psyrri, Alexandra Voutsina, Eleni Politaki, Maria Chimonidou, Eleni Tzanikou, Areti Strati, Sophia Mastoraki
Purpose: Liquid biopsy provides real-time monitoring of tumor evolution and response to therapy through analysis of circulating tumor cells (CTCs) and plasma-circulating tumor DNA (ctDNA). ESR1 epigenetic silencing potentially affects response to end
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::29cfba7eeafd391429bbb1b71b34f35f
https://doi.org/10.1158/1078-0432.c.6524418.v1
https://doi.org/10.1158/1078-0432.c.6524418.v1
Autor:
Linjie Luo, Yan Wang, Sophia Mastoraki, Akshara Singareeka Raghavendra, Juliana Navarro-Yepes, Nicole M. Kettner, Serena Kim, Debasish Tripathy, Kelly Hunt, Khandan Keyomarsi
Publikováno v:
Cancer Research. 83:4346-4346
Background: Cyclin-dependent kinase 4/6 inhibitors (CDK4/6is) in combination with endocrine therapy (ET) have become the mainstay treatment for patients with hormone receptor (ER)-positive, HER2-negative metastatic breast cancer (BC). However, one-th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33ba045ed1f8931f15fb43c1977e2084
https://doi.org/10.1158/1538-7445.am2023-4346
https://doi.org/10.1158/1538-7445.am2023-4346
Autor:
Evangelos Bournakis, Sophia Mastoraki, Dora Londra, Martha Zavridou, Theodoros Rampias, Anastasios Thanos, Evi Lianidou
Publikováno v:
Cancers
Cancers; Volume 13; Issue 18; Pages: 4607
Cancers, Vol 13, Iss 4607, p 4607 (2021)
Cancers; Volume 13; Issue 18; Pages: 4607
Cancers, Vol 13, Iss 4607, p 4607 (2021)
Simple Summary Liquid biopsy provides real-time monitoring of tumor evolution and response to therapy through analysis of circulating tumor cells (CTCs) and plasma-circulating tumor DNA (ctDNA). USP44 is a member of family proteins deubiquitinases, a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4118aa4eb4e71061e42d72bf67cb2379
http://europepmc.org/articles/PMC8467003
http://europepmc.org/articles/PMC8467003
Publikováno v:
The Analyst. 144:6671-6680
Androgen-receptor splice variant 7 (AR-V7) is a highly promising liquid biopsy predictive biomarker showing primary or acquired resistance to novel androgen receptor signaling inhibitors in metastatic castration resistant prostate cancer (mCRPC). We
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::90d36cae7979c2be78a8033769152c43
https://doi.org/10.1039/c9an00999j
https://doi.org/10.1039/c9an00999j
Autor:
Sophia Mastoraki, Evi Lianidou, Apostolos Klinakis, Martha Zavridou, George Koutsodontis, Amanda Psyrri, Areti Strati
Publikováno v:
Scientific Reports, Vol 10, Iss 1, Pp 1-9 (2020)
Scientific Reports
Scientific Reports
We directly compared two different approaches used for Circulating Tumor Cell (CTC) isolation, a size-dependent microfluidic system versus an EpCAM-dependent positive selection for downstream molecular characterization of CTC both at the gene express
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3a365b31d53a9f201d57874062185bdd
https://doi.org/10.1038/s41598-020-63055-y
https://doi.org/10.1038/s41598-020-63055-y
Autor:
Maria Chimonidou, Areti Strati, Athina Markou, V. Georgoulias, Cleo Parisi, Evi Lianidou, Sophia Mastoraki
Publikováno v:
Clinica Chimica Acta. 461:156-164
Background Liquid biopsy is based on minimally invasive blood tests and has the potential to characterize the evolution of a solid tumor in real time, by extracting molecular information from circulating tumor cells (CTCs) and circulating tumor DNA (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55c34c797fd25f464d9346095bead398
https://doi.org/10.1016/j.cca.2016.08.003
https://doi.org/10.1016/j.cca.2016.08.003
Autor:
Areti Strati, Evi Lianidou, Sophia Mastoraki, Evangelos Bournakis, Martha Zavridou, Eleni Tzanikou, Athina Markou
Publikováno v:
Cancers
Volume 12
Issue 5
Cancers, Vol 12, Iss 1188, p 1188 (2020)
Volume 12
Issue 5
Cancers, Vol 12, Iss 1188, p 1188 (2020)
PIM-1 is an oncogene involved in cell cycle progression, cell growth, cell survival and therapy resistance, activated in many types of cancer, and is now considered as a very promising target for cancer therapy. We report for the first time that PIM-
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcff55c0d48c565d463df801cd2e2eee
https://doi.org/10.3390/cancers12051188
https://doi.org/10.3390/cancers12051188
Autor:
Evi Lianidou, Areti Strati, Paul Buderath, Kitty Pavlakis, Sophia Mastoraki, Lydia Giannopoulou, Sabine Kasimir-Bauer
Objective Estrogen receptor, coded by the ESR1 gene, is highly expressed in epithelial ovarian cancer. ESR1 gene is frequently methylated in many types of gynecological malignancies. However, only a few studies attempted to investigate the role of ES
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f9646d473cb14d830749aba0a4d71a91